Korver
Brian E. Korver, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20150351075 | Delivery of push notifications to an inactive computing device - A method performed by a notification handler process running on a device includes receiving a first push notification for a first application while the recipient device is inactive; determining that delivery of the first push notification would cause the device to become active without prompting a user of the device to interact with the first application; in response to determining what delivery of the first push modification would cause, locally storing the first push notification; receiving a second push notification for a second application while the recipient device is still inactive; determining that delivery of the second push notification would cause the device to become active prompting the user to interact with the second application; and in response to determining what delivery of the second push modification would cause, delivering the received second push notification to the second application and the stored first push notification to the first application. | 12-03-2015 |
Clinton Douglas Korver, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20110060621 | VALUE DRIVEN INTEGRATED BUILD-TO-BUY DECISION ANALYSIS SYSTEM AND METHOD - A value-driven build-to-buy decision analysis system and method is provided that addresses and integrates the system analysis for multiple parts of the build-to-buy business cycle. The system and method of the present invention includes a demand component and a supply component. The demand component includes decision analysis components for one or more demand oriented activities in the. build-to-buy cycle, such as selling and buying activities. The supply component includes decision analysis components for one or more supply oriented activities in the build-to-buy cycle, such as product creation, product packaging and product pricing activities. Each decision analysis component utilizes values-based object-oriented analytical models. | 03-10-2011 |
Clinton Douglas Korver, Atherton, CA US
Patent application number | Description | Published |
---|---|---|
20120185479 | SYSTEM AND METHOD FOR ORGANIZING AND MANAGING CONTENT TO FACILITATE DECISION-MAKING - A system is configured to organize content. The system may constitute a decision tool that provides a user with a decision template that enables the user to create a decision record that organizes aspects of a decision that the user considered, the user's reasoning with respect to these aspects in arriving at an ultimate outcome, and/or other information related to the decision. The decision template may include one or more fields into which the user may enter content manually, or the user may search for, and import content related to the decision into the template from, one or more content sources that include relevant content. | 07-19-2012 |
Florian Korver, Paris FR
Patent application number | Description | Published |
---|---|---|
20100058949 | DEVICE FOR BRIDGING A GAP BETWEEN A PLATFORM AND A RAIL VEHICLE - A device includes a fixed portion permanently integrated in a platform, a mobile portion connected to the fixed portion so as to be capable of displacement between stowed and expanded configurations, and elements for driving the mobile portion. In order to improve the device safety, including in particularly dangerous cases such as the drift of the railway vehicle along the platform, the mobile portion is provided with telemeters for constant time measuring of the horizontal distance between them and the vehicle, while control members connected to the telemeters process the measurements from the telemeters in order to provide real-time driving-elements actuation signals according to the measurements so that, in the expanded configuration, the horizontal distance between the free end of the mobile part and the access threshold ( | 03-11-2010 |
Irazya Korver, Den Haag NL
Patent application number | Description | Published |
---|---|---|
20080241445 | Flower Vase and Blank for the Production Thereof - Flower vase made of a watertight, cardboard-like material. Starting from a blank, after fold lines suitably applied have been introduced, a vase is obtained, which is watertight without glue or sealing techniques. In particular it is proposed to design the folding structure such that there are elastic material flaps in the middle of the vase for accommodating a bouquet of flowers closely fitting therein. Because of the folding inwards, a stiff outside of the vase is created. Optional carrying handles, such as cords, can be applied such that this inward-moving effect for retaining a bunch of flowers is reinforced. A vase of this type can be provided with any desired printing and can have any desired dimensions. | 10-02-2008 |
Jacobus Gerardus Korver, Wormer NL
Patent application number | Description | Published |
---|---|---|
20120137930 | Coating Compositions And Process For The Preparation Thereof - A composition and processes for the reduction of the tendency to baking, moisture absorption and/or dust formation of a granulate being susceptible therefore, such as fertilizers, minerals, ores, as well as to obtain stable coloring dispersions, density control of cokes and the reduction of foam in industrial processes, wherein synthetic polymers of fatty alkyl compounds, especially fatty acid esters and fatty-alcohols, fatty amines, fatty amides and fatty ethers, or distillation residues of the original monomers themselves, can be used, are disclosed. The distillation residues are preferably derived from the bottom fraction, obtained by distillation of the fraction being suitable as biodiesel during the biodiesel production process. | 06-07-2012 |
Kirk F. Korver, Salt Lake City, UT US
Patent application number | Description | Published |
---|---|---|
20100063411 | Calibration systems and methods for neural interface devices - A system and method for a neural interface system with integral calibration elements may include a sensor including a plurality of electrodes to detect multicellular signals, an interface to process the signals from the sensor into a suitable control signal for a controllable device, such as a computer or prosthetic limb, and an integrated calibration routine to efficiently create calibration output parameters used to generate the control signal. A graphical user interface may be used to make various portions of the calibration and signal processing configuration more efficient and effective. | 03-11-2010 |
Kirk Frederick Korver, Reno, NV US
Kristine Michelle Korver, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100325776 | Hand-Covering Garment - A hand-covering garment includes a first hand cover; a first sleeve non-removably connected to the first hand cover such that a first hand of a user may pass into an open end of the first sleeve, through the first sleeve, and out a second end of the first sleeve into the first hand cover, but may not pass out the second end without passing into the first hand cover; a second hand cover; a second sleeve non-removably connected to the second hand cover such that a second hand of the user may pass into an open end of the second sleeve, through the second sleeve, and out a second end of the second sleeve into the second hand cover, but may not pass out the second end without passing into the second hand cover; and a retaining element non-removably connected to the first sleeve and the second sleeve. | 12-30-2010 |
Wouter Korver, South San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20120201827 | ANTI-CD38 ANTIBODIES - Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies. | 08-09-2012 |
20130171154 | ANTI-CD38 ANTIBODIES - Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies. | 07-04-2013 |
20140155584 | CONJUGATED ANTI-CD38 ANTIBODIES - Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies. | 06-05-2014 |
20150203587 | ANTI-CD38 ANTIBODIES - Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies. | 07-23-2015 |
20150291702 | CONJUGATED ANTI-CD38 ANTIBODIES - Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies. | 10-15-2015 |
Wouter Korver, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090181009 | ANTIBODIES TO NTB-A - Anti-NTB-A antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind NTB-A and treat diseases, such as hematologic malignancies, which are characterized by expression of NTB-A. | 07-16-2009 |
20100028906 | REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATION - The present embodiments relate to methods of identifying and creating human or humanized antibodies that possess a reduced risk of inducing a Human Anti-Human Antibody (HAHA) response when they are applied to a human host. Other methods are directed to predicting the likelihood of a HAHA response occurring. Methods for screening for anti-HAHA compounds are also included. Methods for determining if various conditions for administering an antibody to a subject enhance or suppress a HAHA response are also included. | 02-04-2010 |
20100285037 | ANTIBODIES TO CLL-1 - Anti-CLL-1 antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind CLL-1 and treat diseases, such as hematologic malignancies, which are characterized by expression of CLL-1. | 11-11-2010 |
20100291108 | ANTIBODIES TO IREM-1 - Anti-IREM-1 antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind IREM-1 and treat diseases, such as hematologic malignancies, which are characterized by expression of IREM-1. | 11-18-2010 |
20110171204 | ANTIBODIES TO NTB-A - Anti-NTB-A antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind NTB-A and treat diseases, such as hematologic malignancies, which are characterized by expression of NIB-A. | 07-14-2011 |
20120219976 | REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATION - The present embodiments relate to methods of identifying and creating human or humanized antibodies that possess a reduced risk of inducing a Human Anti-Human Antibody (HAHA) response when they are applied to a human host. Other methods are directed to predicting the likelihood of a HAHA response occurring. Methods for screening for anti-HAHA compounds are also included. Methods for determining if various conditions for administering an antibody to a subject enhance or suppress a HAHA response are also included. | 08-30-2012 |
20130273077 | ANTIBODIES TO NTB-A - Anti-NTB-A antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind NTB-A and treat diseases, such as hematologic malignancies, which are characterized by expression of NIB-A. | 10-17-2013 |
20130344514 | REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATION - The present embodiments relate to methods of identifying and creating human or humanized antibodies that possess a reduced risk of inducing a Human Anti-Human Antibody (HAHA) response when they are applied to a human host. Other methods are directed to predicting the likelihood of a HAHA response occurring. Methods for screening for anti-HAHA compounds are also included. Methods for determining if various conditions for administering an antibody to a subject enhance or suppress a HAHA response are also included. | 12-26-2013 |
20140248238 | POLYPEPTIDE CONSTRUCTS AND USES THEREOF - The present invention provides a polypeptide construct comprising a peptide or polypeptide signaling ligand linked to an antibody or antigen binding portion thereof which binds to a cell surface-associated antigen, wherein the ligand comprises at least one amino acid substitution or deletion which reduces its potency on cells lacking expression of said antigen. | 09-04-2014 |